Free Trial

Genus (GNS) Competitors

Genus logo
GBX 1,993 +29.00 (+1.48%)
As of 10:51 AM Eastern

GNS vs. HWDN, DPH, IGG, CTY, SMWH, CAR, PRP, AUK, BAY, and STG

Should you be buying Genus stock or one of its competitors? The main competitors of Genus include Howden Joinery Group (HWDN), Dechra Pharmaceuticals (DPH), IG Group (IGG), City of London (CTY), WH Smith (SMWH), Carclo (CAR), Prime People (PRP), Aukett Swanke Group (AUK), Bay Capital (BAY), and Strip Tinning (STG). These companies are all part of the "personal services" industry.

Genus vs. Its Competitors

Howden Joinery Group (LON:HWDN) and Genus (LON:GNS) are both consumer cyclical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, community ranking, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

Howden Joinery Group pays an annual dividend of GBX 21 per share and has a dividend yield of 2.4%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.6%. Howden Joinery Group pays out 45.0% of its earnings in the form of a dividend. Genus pays out 265.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Howden Joinery Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Howden Joinery Group currently has a consensus target price of GBX 971.33, suggesting a potential upside of 10.76%. Genus has a consensus target price of GBX 2,150, suggesting a potential upside of 8.37%. Given Howden Joinery Group's higher possible upside, equities analysts clearly believe Howden Joinery Group is more favorable than Genus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Howden Joinery Group
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Genus
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Howden Joinery Group has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Genus has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500.

Howden Joinery Group has a net margin of 10.82% compared to Genus' net margin of 1.18%. Howden Joinery Group's return on equity of 25.70% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
Howden Joinery Group10.82% 25.70% 10.70%
Genus 1.18%1.41%3.31%

Howden Joinery Group has higher revenue and earnings than Genus. Howden Joinery Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Howden Joinery Group£2.34B2.05£253.42M£46.6518.80
Genus£666.67M1.95£7.87M£12.06164.46

70.6% of Howden Joinery Group shares are owned by institutional investors. Comparatively, 77.8% of Genus shares are owned by institutional investors. 0.5% of Howden Joinery Group shares are owned by insiders. Comparatively, 0.8% of Genus shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Howden Joinery Group received 315 more outperform votes than Genus when rated by MarketBeat users. Likewise, 72.37% of users gave Howden Joinery Group an outperform vote while only 70.60% of users gave Genus an outperform vote.

CompanyUnderperformOutperform
Howden Joinery GroupOutperform Votes
668
72.37%
Underperform Votes
255
27.63%
GenusOutperform Votes
353
70.60%
Underperform Votes
147
29.40%

In the previous week, Howden Joinery Group had 2 more articles in the media than Genus. MarketBeat recorded 3 mentions for Howden Joinery Group and 1 mentions for Genus. Howden Joinery Group's average media sentiment score of 0.47 beat Genus' score of 0.30 indicating that Howden Joinery Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Howden Joinery Group
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Genus
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Howden Joinery Group beats Genus on 15 of the 19 factors compared between the two stocks.

Get Genus News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNS vs. The Competition

MetricGenusBiotechnology IndustryMedical SectorLON Exchange
Market Cap£1.30B£127.96M£5.60B£2.93B
Dividend Yield1.69%3.74%5.28%4.90%
P/E Ratio164.463.2927.23123.18
Price / Sales1.954,386.11417.65243,308.49
Price / Cash50.5613.1938.2528.07
Price / Book2.4037.877.124.75
Net Income£7.87M-£91.56M£3.23B£5.91B
7 Day Performance-0.10%1.74%2.74%6.94%
1 Month Performance-6.83%7.18%8.94%16.69%
1 Year Performance11.46%174.10%31.59%77.68%

Genus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNS
Genus
0.469 of 5 stars
GBX 1,993
+1.5%
GBX 2,150
+7.9%
+10.5%£1.31B£666.67M165.20480Gap Down
High Trading Volume
HWDN
Howden Joinery Group
2.6522 of 5 stars
GBX 859.50
+1.1%
GBX 971.33
+13.0%
+2.2%£4.69B£2.34B18.4212,000Positive News
DPH
Dechra Pharmaceuticals
N/AN/AN/AN/A£4.40B£761.50M-15,464.002,457
IGG
IG Group
3.1761 of 5 stars
GBX 1,079.48
+0.3%
GBX 1,466
+35.8%
+35.8%£3.83B£913.00M7.202,754Positive News
CTY
City of London
N/AGBX 487
+0.2%
N/A+17.8%£2.41B£307.08M8.20N/ADividend Announcement
SMWH
WH Smith
3.4265 of 5 stars
GBX 1,071
+1.7%
GBX 1,430
+33.5%
-9.4%£1.38B£1.83B22.0914,935Dividend Increase
Analyst Forecast
Gap Down
CAR
Carclo
N/AGBX 38.80
-2.8%
N/A+109.8%£28.49M£132.66M-8.641,059
PRP
Prime People
N/AN/AN/AN/A£8.15M£19.72M10.9813,100Gap Down
AUK
Aukett Swanke Group
N/AN/AN/AN/A£5.46M£23.61M-6.3232,200Gap Down
BAY
Bay Capital
N/AGBX 5.50
flat
N/A-13.7%£3.85MN/A-2.712Gap Down
STG
Strip Tinning
N/AGBX 18.25
-3.9%
N/A-73.0%£3.33M£10.09M-1.114,060Gap Down

Related Companies and Tools


This page (LON:GNS) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners